APA (7th ed.) Citation

Langlais, B., Dueck, A. C., Kosiorek, H. E., Mead-Harvey, C., Meek, E., Rogak, L., . . . Mazza, G. L. (2024). Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms. Leukemia & Lymphoma, 65(10), 1465. https://doi.org/10.1080/10428194.2024.2356058

Chicago Style (17th ed.) Citation

Langlais, Blake, et al. "Impact of Gender Representativeness in Online Symptom Survey and Clinical Trial Participation Among Patients with Myeloproliferative Neoplasms." Leukemia & Lymphoma 65, no. 10 (2024): 1465. https://doi.org/10.1080/10428194.2024.2356058.

MLA (9th ed.) Citation

Langlais, Blake, et al. "Impact of Gender Representativeness in Online Symptom Survey and Clinical Trial Participation Among Patients with Myeloproliferative Neoplasms." Leukemia & Lymphoma, vol. 65, no. 10, 2024, p. 1465, https://doi.org/10.1080/10428194.2024.2356058.